John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 1,949 shares at $256.23 ($501K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Open-market sale of $501k ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $256.23 | 741 | $190K | 37.9% |
| 2 | $257.59 | 859 | $221K | 44.1% |
| 3 | $258.28 | 200 | $52K | 10.3% |
| 4 | $258.81 | 149 | $39K | 7.7% |
| Total | $257.24 avg | 1,949 | $501K | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |